Kati Sarnola

6PUBLICATIONS
6CO-AUTHORS
Clinical pharmacology and therapeuticsCancer therapy (excl. chemotherapy and radiation therapy)Medical biotechnology diagnostics (incl. biosensors)Traditional Chinese medicine and treatmentsPharmacology and pharmaceutical sciences not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 19, 2026
Use Patterns of Novel Janus Kinase Inhibitors After the First Safety Alerts: A Nationwide Register-Based Time Series Analysis.

|Oct 21, 2024
New cancer medicines in Europe 2010-2020: comparison of medicines with or without extensions of indications.

Anna-Maria Ruuskanen, Terhi Kurko, Kati Sarnola

|May 07, 2020
Physicians' perceptions of the uptake of biosimilars: a systematic review.

Kati Sarnola, Merja Merikoski, Johanna Jyrkkä

|Jun 08, 2019
A regulatory perspective on the availability of medicines and medicine shortages in outpatient care: case Finland.

Kati Sarnola, Johanna Linnolahti

|Apr 11, 2018
Policies and availability of orphan medicines in outpatient care in 24 European countries.

Kati Sarnola, Riitta Ahonen, Jaana E Martikainen

|Jun 29, 2017
The reasons behind medicine shortages from the perspective of pharmaceutical companies and pharmaceutical wholesalers in Finland.

Kati Heiskanen, Riitta Ahonen, Risto Kanerva

Pageof 1

Frequent Collaborators

1 joint publications

Anna-Maria Ruuskanen

1 joint publications

Terhi Kurko

1 joint publications

Hanna Koskinen

1 joint publications

Jarno Rutanen